Table A1.
Differences in the median of leukocytes subpopulation percentages between healthy patients (A), patients with COVID-19 without interstitial lesions on chest X-ray ((B): COVID-19 X-ray (−)) and patients with COVID-19 with interstitial lesions on chest X-ray ((C): COVID-19 X-ray (+)). Data expressed as median (Q1–Q3).
| [% of Total Leukocytes] | Control Group n = 20 (A) Median (Q1-Q3) |
COVID-19 X-ray (-) n = 9 (B) Median (Q1-Q3) | COVID-19 X-ray (+) n = 14 (C) Median (Q1-Q3) | p < 0.05 * Group A-B-C ANOVA, Kruskal-Wallis | p < 0.05 * Group, in Groups Post-Hoc |
|---|---|---|---|---|---|
| Lymphocytes | 38.3 (33.2–46.3) | 49.8 (24.7–57.1) | 27.6 (13.1–37.4) | 0.0637 | - |
| T Lymphocytes | 30.5 (24.6–40.9) | 36.2 (13.9–43.0) | 19.4 (7.8–24.8) | * 0.0129 | * A-C 0.0140 |
| CD4 cells | 18.6 (13.6–22.0) | 23.1 (10.3–25.9) | 8.0 (4.8–14.4) | * 0.0026 | * A-C 0.0063 * B-C 0.0131 |
| CD8 cells | 10.5 (7.8–13.2) | 9.4 (4.2–15.4) | 8.5 (3.6–12.3) | 0.4905 | - |
| Ratio CD4/CD8 | 1.8 (1.5–2.2) | 2.1 (1.4–3.5) | 1.3 (0.6–2.4) | 0.1460 | - |
| Lymphocytes B [%] | 3.9 (3.0–5.0) | 2.7 (1.7–3.2) | 2.1 (1.3–5.1) | 0.0810 | - |
| NK cells [%] | 4.2 (2.8–7.0) | 6.5 (4.1–9.1) | 4.3 (1.5–9.1) | 0.4628 | - |
| Neutrophils | 47.3 (42.1–57.3) | 37.6 (29.7–69.4) | 62.9 (49.4–77.5) | * 0.0229 | * B-C 0.0230 |
| Eosinophils [%] | 2.2 (0.5–3.3) | 1.7 (0.9–3.6) | 0.9 (0.0–2.2) | * 0.0149 | * A-C 0.0150 |
| Basophils [%] | 0.7 (0.5–1.2) | 0.6 (0.3–1.5) | 0.2 (0.0–0.5) | 0.0511 | - |
| Monocytes [%] | 10.2 (6.8–11.5) | 7.2 (4.1–8.1) | 7.1 (6.2–11.9) | 0.1611 | - |